Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (6 ops.)
Latest filing published 02 Oct 2026 for Ocumension Therapeutics - B.
Filing timeline
BuySaleLiu Ye
Insider track record
Disclosed buys
4
Disclosed sells
6
Signal history
Closed purchases
Market purchases
4
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Liu Ye: trading record in brief
Liu Ye discloses dealings in 2 companies, chiefly Ocumension Therapeutics - B and EyePoint, Inc. In total, 66 filings cover trades dated from 10 July 2020 to 28 September 2026.
Market trades split into 4 purchases and 6 sales (€51.9M). The totals do not cover 6 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings no purchases and 1 sale.
On 2 October 2026 came the latest disclosure, a transaction in Ocumension Therapeutics - B. The most recent open-market purchase was published on 27 June 2025, 485 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Liu Ye
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations65 total
203,459 sharesShareXHKGHKEX:DA20260930E00524
203,459 sharesShareXHKGHKEX:DA20260702E00732
1,080,000 sharesShareXHKGHKEX:DA20250918E00073
1,532,500 sharesShareXHKGHKEX:DA20250820E00368
812,625 sharesShareXHKGHKEX:DA20250708E00041
8,138,350 sharesShareXHKGHKEX:DA20250627E00020
Canonical exit: 22 Sept 2025 (T+90)
812,625 sharesShareXHKGHKEX:DA20250410E00391
647,000 sharesShareXHKGHKEX:DA20250219E00199
1,319,000 sharesShareXHKGHKEX:DA20250121E00443
812,625 sharesShareXHKGHKEX:DA20250107E00038
812,625 sharesShareXHKGHKEX:DA20241009E00527
1,080,000 sharesShareXHKGHKEX:DA20240912E00382
1,625,250 sharesShareXHKGHKEX:DA20240716E00507
1,910,500 shares@ US$19.4571.5% of flowCommon Stock, $0.001 par valueSEC:0001562180-24-000466:0
580,000 sharesShareXHKGHKEX:DA20240111E00618
2,000,000 sharesShareXHKGHKEX:DA20240111E00616
2,131,000 sharesShareXHKGHKEX:DA20240109E00033
812,625 sharesShareXHKGHKEX:DA20240105E00474
266,242 shares@ US$18.41Common Stock, $0.001 par valueSEC:0001562180-23-008222:1
733,758 shares@ US$19.9128.5% of flowCommon Stock, $0.001 par valueSEC:0001562180-23-008222:0
812,625 sharesShareXHKGHKEX:DA20231003E00302
1,080,000 sharesShareXHKGHKEX:DA20230915E00425
812,625 sharesShareXHKGHKEX:DA20230706E00091
1 shares@ US$6.000.0% of flowCommon Stock, $0.001 par valueSEC:0001562180-23-004632:0
500 sharesShareXHKGHKEX:DA20230509E00027
25 of 65 declarations
